Clinical Trial Update: Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous GPC3-targeted CAR T cells (RPCAR01) for advanced or metastatic hepatocellular carcinoma; the study status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• RPCAR01

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma | Phase 1 | Status: SUSPENDED